4//SEC Filing
Piacquad David 4
Accession 0001127602-21-011714
CIK 0000318154other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 6:33 PM ET
Size
5.3 KB
Accession
0001127602-21-011714
Insider Transaction Report
Form 4
AMGEN INCAMGN
Piacquad David
SVP, Business Development
Transactions
- Tax Payment
Common Stock
2021-03-19$244.42/sh−991$242,220→ 44,565 total
Footnotes (2)
- [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 335 RSUs which vest on 5/1/2021; 642 RSUs which vest in installments of 316 on 4/27/2021 and 326 on 4/27/2022; 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023; and 1,269 RSUs which vest in installments of 418 on 5/5/2022, 419 on 5/5/2023 and 432 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F2]These shares include 234 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001602343
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 6:33 PM ET
- Size
- 5.3 KB